查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2049682

神經修復與再生市場報告：按手術類型、產品類型、最終用戶類型和地區分類（2026-2034 年）

Nerve Repair and Regeneration Market Report by Surgery, Product, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

2025年全球神經修復再生市場規模達103億美元。展望未來，IMARC Group預測，從2026年到2034年，該市場將以9.08%的複合年成長率成長，到2034年達到231億美元。

神經修復與再生（NRaR）是指利用神經組織工程技術治療神經損傷的過程。它促進新神經元、神經膠質細胞、髓鞘、軸突和突觸的再生，並有助於恢復神經損​​傷後的正常功能。神經損傷通常由壓迫、鈍性創傷、牽拉或橫斷引起。 NRaR涉及生物材料以及各種神經刺激和神經調控裝置的使用。生物材料包括神經導管、神經保護材料、神經繃帶和神經連接器。這些材料可用於直接神經移植、神經移植、幹細胞療法，以及經皮、經顱磁刺激、脊髓刺激、深部腦部刺激、薦骨神經和迷走神經刺激。

神經修復與再生市場的發展趨勢：

阿茲海默症、帕金森氏症、肌萎縮性側索硬化症（ALS）、多發性硬化症和多重系統退化症症等慢性神經系統疾病的日益普遍是推動市場成長的主要因素。此外，易患這些疾病的老年人口不斷成長，以及神經損傷病例的增加，也促進了市場成長。全球各地的醫院、門診手術中心（ASC）和其他醫療機構都在提供新的神經再生（NRaR）解決方案，用於神經系統疾病的早期診斷和治療。此外，幹細胞療法的各項技術進步以及創新神經調控設備的開發也在推動市場成長。內源性幹細胞廣泛應用於神經發生、神經修復和外源性神經幹細胞移植，以有效修復和替換受損的中樞神經系統組織。預計推動市場成長的其他因素包括公共醫療費用支出的增加和醫療保健基礎設施的顯著改善，尤其是在開發中國家。

本報告解答的主要問題

  • 到 2025 年，全球神經修復和再生市場規模將達到多少？
  • 2026年至2034年全球神經修復和再生市場的預期成長率是多少？
  • 全球神經修復和再生市場的主要促進因素是什麼？
  • 新冠疫情對全球神經修復和再生市場產生了哪些影響？
  • 依手術類型分類，全球神經修復和再生市場的組成是怎樣的？
  • 全球神經修復和再生市場按產品類型分類的組成是怎樣的？
  • 全球神經修復和再生市場按最終用戶分類的情況如何？
  • 全球神經修復和再生市場的主要區域有哪些？
  • 全球神經修復和再生市場的主要參與者/公司有哪些？

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球神經修復與再生市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依手術類型分類

  • 直接神經修復/神經縫合
  • 神經移植
  • 幹細胞療法
  • 神經刺激及神經調控手術

第7章 市場區隔：依產品分類

  • 生物材料
  • 神經刺激和神經調節裝置
    • 主要部分
      • 脊髓刺激設備
      • 深部腦部刺激器
      • 薦骨神經刺激器
      • 迷走神經刺激設備
      • 胃電刺激設備

第8章 市場區隔：依最終用戶分類

  • 醫院和診所
  • 門診手術中心

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Abbott Laboratories
    • Alafair Biosciences Inc.
    • AxoGen Inc.
    • Baxter International Inc.
    • Boston Scientific Corporation
    • Collagen Matrix Inc.
    • Integra Lifesciences Corporation
    • Medtronic plc
    • Polyganics BV
    • Soterix Medical Inc.
    • Stryker Corporation
    • Synapse Biomedical Inc.
Product Code: SR112026A4159

The global nerve repair and regeneration market size reached USD 10.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 23.1 Billion by 2034, exhibiting a growth rate (CAGR) of 9.08% during 2026-2034.

Nerve repair and regeneration (NRaR) refers to a neural tissue engineering process used for the treatment of a nerve injury. It facilitates the regrowth of new neurons, glial cells, myelin, axons and synapses. It also aids in restoring the normal functioning of the nerve after nerve damage, which is usually caused by pressure, blunt trauma, stretching or cutting of a nerve. NRaR involves the use of biomaterials and various neuro-stimulation and neuromodulation devices. Biomaterials include nerve conduits, nerve protectors, nerve wraps, and nerve connectors. They are used for direct neuropathy, nerve grafting, stem cell therapy and transcutaneous, transcranial magnetic, spinal cord, deep brain, sacral nerve and vagus nerve stimulation.

NERVE REPAIR AND REGENERATION MARKET TRENDS:

The increasing prevalence of chronic neurological disorders, such as Alzheimer's, Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis and multiple system atrophy, is among the key factors driving the market growth. Moreover, the rising geriatric population, which is more susceptible to such ailments, and escalating instances of nerve injuries are providing a thrust to the growth of the market. Hospitals, ambulatory surgical centers (ASCs) and other healthcare institutes across the globe are providing novel NRaR solutions for timely diagnosis and treatment of neurological disorders. Additionally, various technological advancements in stem cell therapy and the development of innovative neuromodulation devices, are acting as other growth-inducing factors. Endogenous stem cells are being widely used in neurogenesis, neural repair and exogenous neural stem cell transplantation for effective repair and replacement of damaged tissues in the central nervous system. Other factors, including rising healthcare expenditures of the masses, along with the significant improvements in the medical infrastructure, especially in the developing economies, are anticipated to drive the market toward growth.

KEY MARKET SEGMENTATION:

Breakup by Surgery:

  • Direct Nerve Repair/Neurorrhaphy
  • Nerve Grafting
  • Stem Cell Therapy
  • Neurostimulation and Neuromodulation Surgeries

Breakup by Product:

  • Biomaterial
  • Neurostimulation and Neuromodulation Devices
    • Spinal Cord Stimulation Devices
    • Deep Brain Stimulation Devices
    • Sacral Nerve Stimulation Devices
    • Vagus Nerve Stimulation Devices
    • Gastric Electric Stimulation Devices

Breakup by End User:

  • Hospitals and Clinics
  • Ambulatory Surgical Centers

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

COMPETITIVE LANDSCAPE:

The report has also provided a comprehensive analysis of the competitive landscape in the global nerve repair and regeneration market. Detailed profiles of all major companies have also been provided. Some of the companies covered include:

  • Abbott Laboratories
  • Alafair Biosciences Inc.
  • AxoGen Inc.
  • Baxter International Inc.
  • Boston Scientific Corporation
  • Collagen Matrix Inc
  • Integra Lifesciences Corporation
  • Medtronic plc
  • Polyganics BV
  • Soterix Medical Inc.
  • Stryker Corporation
  • Synapse Biomedical Inc.

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1.What was the size of the global nerve repair and regeneration market in 2025?
  • 2.What is the expected growth rate of the global nerve repair and regeneration market during 2026-2034?
  • 3.What are the key factors driving the global nerve repair and regeneration market?
  • 4.What has been the impact of COVID-19 on the global nerve repair and regeneration market?
  • 5.What is the breakup of the global nerve repair and regeneration market based on the surgery?
  • 6.What is the breakup of the global nerve repair and regeneration market based on the product?
  • 7.What is the breakup of the global nerve repair and regeneration market based on the end user?
  • 8.What are the key regions in the global nerve repair and regeneration market?
  • 9.Who are the key players/companies in the global nerve repair and regeneration market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Nerve Repair and Regeneration Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Surgery

  • 6.1 Direct Nerve Repair/Neurorrhaphy
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Nerve Grafting
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Stem Cell Therapy
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Neurostimulation and Neuromodulation Surgeries
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Biomaterial
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Neurostimulation and Neuromodulation Devices
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Spinal Cord Stimulation Devices
      • 7.2.2.2 Deep Brain Stimulation Devices
      • 7.2.2.3 Sacral Nerve Stimulation Devices
      • 7.2.2.4 Vagus Nerve Stimulation Devices
      • 7.2.2.5 Gastric Electric Stimulation Devices
    • 7.2.3 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgical Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Alafair Biosciences Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 AxoGen Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Baxter International Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Boston Scientific Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Collagen Matrix Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Integra Lifesciences Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Medtronic plc
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Polyganics BV
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Soterix Medical Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Stryker Corporation
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Synapse Biomedical Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Nerve Repair and Regeneration Market: Major Drivers and Challenges
  • Figure 2: Global: Nerve Repair and Regeneration Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Nerve Repair and Regeneration Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Nerve Repair and Regeneration Market: Breakup by Surgery (in %), 2025
  • Figure 5: Global: Nerve Repair and Regeneration Market: Breakup by Product (in %), 2025
  • Figure 6: Global: Nerve Repair and Regeneration Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Nerve Repair and Regeneration Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Nerve Repair and Regeneration (Direct Nerve Repair/Neurorrhaphy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Nerve Repair and Regeneration (Direct Nerve Repair/Neurorrhaphy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Nerve Repair and Regeneration (Nerve Grafting) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Nerve Repair and Regeneration (Nerve Grafting) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Nerve Repair and Regeneration (Stem Cell Therapy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Nerve Repair and Regeneration (Stem Cell Therapy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Nerve Repair and Regeneration (Neurostimulation and Neuromodulation Surgeries) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Nerve Repair and Regeneration (Neurostimulation and Neuromodulation Surgeries) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Nerve Repair and Regeneration (Biomaterial) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Nerve Repair and Regeneration (Biomaterial) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Nerve Repair and Regeneration (Neurostimulation and Neuromodulation Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Nerve Repair and Regeneration (Neurostimulation and Neuromodulation Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Nerve Repair and Regeneration (Hospitals and Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Nerve Repair and Regeneration (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Nerve Repair and Regeneration (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Nerve Repair and Regeneration (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: North America: Nerve Repair and Regeneration Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: North America: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: United States: Nerve Repair and Regeneration Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: United States: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Canada: Nerve Repair and Regeneration Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Canada: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Asia-Pacific: Nerve Repair and Regeneration Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Asia-Pacific: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: China: Nerve Repair and Regeneration Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: China: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Japan: Nerve Repair and Regeneration Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Japan: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: India: Nerve Repair and Regeneration Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: India: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: South Korea: Nerve Repair and Regeneration Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: South Korea: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Australia: Nerve Repair and Regeneration Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Australia: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Indonesia: Nerve Repair and Regeneration Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Indonesia: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Others: Nerve Repair and Regeneration Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Others: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Europe: Nerve Repair and Regeneration Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Europe: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Germany: Nerve Repair and Regeneration Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Germany: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: France: Nerve Repair and Regeneration Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: France: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: United Kingdom: Nerve Repair and Regeneration Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: United Kingdom: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Italy: Nerve Repair and Regeneration Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Italy: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Spain: Nerve Repair and Regeneration Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Spain: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Russia: Nerve Repair and Regeneration Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Russia: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Others: Nerve Repair and Regeneration Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Others: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Latin America: Nerve Repair and Regeneration Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Latin America: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Brazil: Nerve Repair and Regeneration Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Brazil: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Mexico: Nerve Repair and Regeneration Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Mexico: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Others: Nerve Repair and Regeneration Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Others: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Middle East and Africa: Nerve Repair and Regeneration Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Middle East and Africa: Nerve Repair and Regeneration Market: Breakup by Country (in %), 2025
  • Figure 72: Middle East and Africa: Nerve Repair and Regeneration Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Global: Nerve Repair and Regeneration Industry: SWOT Analysis
  • Figure 74: Global: Nerve Repair and Regeneration Industry: Value Chain Analysis
  • Figure 75: Global: Nerve Repair and Regeneration Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Nerve Repair and Regeneration Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Nerve Repair and Regeneration Market Forecast: Breakup by Surgery (in Million USD), 2026-2034
  • Table 3: Global: Nerve Repair and Regeneration Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 4: Global: Nerve Repair and Regeneration Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Nerve Repair and Regeneration Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Nerve Repair and Regeneration Market: Competitive Structure
  • Table 7: Global: Nerve Repair and Regeneration Market: Key Players